2-Chlorocinnamic acid → (E)-3-(2-Chloro-phenyl)-N-[1-(5,5-difluoro-hexyl)-1H-pyrazol-3-yl]-acrylamide
Reaction equation
[F:1][C:2]([F:14])([CH3:13])[CH2:3][CH2:4][CH2:5][CH2:6][N:7]1[CH:11]=[CH:10][C:9]([NH2:12])=[N:8]1.[Cl:15][C:16]1[CH:21]=[CH:20][CH:19]=[CH:18][C:17]=1/[CH:22]=[CH:23]/[C:24](O)=[O:25]>>[Cl:15][C:16]1[CH:21]=[CH:20][CH:19]=[CH:18][C:17]=1/[CH:22]=[CH:23]/[C:24]([NH:12][C:9]1[CH:10]=[CH:11][N:7]([CH2:6][CH2:5][CH2:4][CH2:3][C:2]([F:1])([F:14])[CH3:13])[N:8]=1)=[O:25]Participants
3
Procedure
Following general procedure B, starting from 1-(5,5-difluoro-hexyl)-1H-pyrazol-3-ylamine and (E)-3-(2-chloro-phenyl)-acrylic acid. LC-MS-conditions 05b: tR=1.13 min; [M+H]+=368.25.
Sources & evidence
- ORD record
- ord-700e6b41963747388c150d5f92c29b5d
- Source dataset
- uspto-grants-2012_10
- Patent number
- US08288419B2
Reaction notes
Loading…